Amolyt Pharma raised €129M in a Series C round in Jan 2023. The company is based in Lyon, France. Investors in the round: Andera Partners, ATEM, Credit Agricole Creation and 13 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
